Figure 2.

Kaplan‐Meier analysis of recurrence‐free (RFS), distant metastasis‐free (DMFS), overall survival (OS), and melanoma‐specific survival (MSS) outcomes by combined gene expression profile (GEP) and nodal risk classification. RFS, DMFS, OS, and MSS rates for patients with cutaneous melanoma located in the head and neck (n = 157) using molecular GEP class and clinical nodal status in Kaplan‐Meier analysis. Tables below curves show the number of patients with each GEP class and a sentinel lymph node status combination, 5‐year survival rates for the outcome with 95% confidence intervals, and number of events with percentages experiencing the event. P‐values determined by log rank test for all comparisons